课题基金 / 基金详情

NIAMS Clinical Research Center for Rheumatoid Disease

NIAMS Clinical Research Center for Rheumatoid Disease
NIAMS 类风湿疾病临床研究中心
批准号:
6897499
负责人:
RICHARD M. SILVER
金额:
$118.87万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-15 至 2008-03-31

项目摘要

项目成果

RICHARD M. SILVER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):南卡罗来纳州医科大学将建立一个多学科临床研究中心(MCRC),用于研究非裔美国人的风湿性疾病。该MCRC将重点关注硬皮病(SSc)和系统性红斑狼疮(SLE),这两种风湿性疾病不成比例地影响非洲裔美国人社区。在三个关键领域的杰出领导-流变学,生物测定/流行病学和卫生服务研究-为成功设计和实施有意义的临床研究提供了一个框架,在这一研究不足的患者群体。提出了三个项目和三个支撑核心。项目A旨在研究SSc和正常成纤维细胞中TGF-β和鞘脂信号通路之间的相互作用。拟议的研究将阐明这种迄今未知的相互作用,以阐明TGF-β信号传导与其他细胞信号传导途径整合导致纤维化的机制。项目B涉及一个重要的未充分研究的领域,即SLE女性青少年的心理社会方面,其中大多数是非洲裔美国人。MCRC研究人员将评估适应过程和调整与健康相关的生活质量之间的关联,并将进行一项干预性试验,旨在提高这些患者的适应能力和生活质量。项目C将讨论狼疮性肾炎发病率的不同种族趋势这一重要问题。非裔美国人狼疮患者的死亡率增加,而白人狼疮患者的死亡率保持稳定,这种差异不能仅由社会经济地位的差异来解释。利用卡罗莱纳狼疮研究和海岛古拉人口的独特资源,MCRC研究人员将解决遗传和环境对狼疮肾炎的发展和进展的影响。这些项目以及MCRC未来开发的试点项目将由两个核心服务:(1)方法学核心将提供严格的方法学和生物统计学支持;(2)患者资源核心将确保MCRC研究人员能够接触到临床特征良好的非裔美国人患者人群,并从中获得和储存生物样本。该MCRC将促进基础研究转化为临床竞技场,支持急需的行为研究,并对影响少数民族和妇女的风湿性疾病进行流行病学和卫生服务研究,从而体现NIAMS战略计划中提出的研究的“交叉”性质。
英文摘要
DESCRIPTION (provided by applicant): The Medical University of South Carolina will establish a Multidisciplinary Clinical Research Center (MCRC) for the Study of Rheumatic Diseases in African-Americans. This MCRC will focus on scleroderma (SSc) and systemic lupus erythematosus (SLE), two rheumatic diseases that disproportionately affect the African-American community. Outstanding leadership in three key areas - Rheumatology, Biometry/Epidemiology, and Health Services Research - provides a framework for successful design and implementation of meaningful clinical research in this understudied population of patients. Three projects and three supporting cores are proposed. Project A is designed to study the interactions between TGF-beta and sphingolipid signaling pathways in SSc and normal fibroblasts. The proposed studies will elucidate this heretofore-unknown interaction to shed light on the mechanism whereby TGF-beta signaling is integrated with other cellular signaling pathways leading to fibrosis. Project B addresses an important understudied area, namely psychosocial aspects of female adolescents with SLE, the majority of whom are African-American. MCRC investigators will assess the associations between adaptational processes and adjustment and health-related quality of life, and will conduct an interventional trial designed to enhance adjustment and quality of life for these patients. Project C will address the important issue of divergent racial trends in morbidity from lupus nephritis. Mortality has increased for African-American lupus patients while remaining stable in Caucasian lupus patients, and this divergence cannot be accounted for by differences in socioeconomic status alone. Utilizing the unique resources of the Carolina Lupus Study and the sea island Gullah population, MCRC investigators will address genetic and environmental influences on the development and progression of lupus nephritis. Each of these projects, as well as future pilot projects to be developed by the MCRC, will be served by two Cores: (1) a Methodology Core will provide rigorous methodological and biostatistical support; and (2) a Patient Resource Core will assure MCRC investigators access to a population of African-American patients who are clinically well characterized and from whom biological samples are obtained and stored. This MCRC will facilitate the translation of basic research into the clinical arena, support much needed behavioral research, and conduct epidemiology and health services research on rheumatic diseases affecting minorities and women disproportionately, thus exemplifying the "cross-cutting" nature of research proposed in NIAMS's strategic plan.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
Defective c-MET signaling in African American scleroderma patients
Defective c-MET signaling in African American scleroderma patients
CLINICAL TRIAL: APPLE STUDY
海外基金